Becton, Dickinson and Company Stock
Stocks
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
05:00:02 11/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 212.61 USD | -1.23% |
|
+7.29% | +9.55% |
| 11-10 | Waters Says US FDA Clearance Obtained for Leukemia, Lymphoma Clinical Tests | MT |
| 11-07 | TD Cowen Adjusts Becton, Dickinson Price Target to $214 From $182 | MT |
| Market Cap | 57.91B 51.94B 47.86B 43.47B 82.27B 5,430B 84.56B 573B 228B 2,909B 217B 213B 9,196B | P/E 2026 |
43.8x | P/E 2027 * | 28.9x |
|---|---|---|---|---|---|
| Enterprise Value | 73.8B 66.18B 60.99B 55.39B 105B 6,919B 108B 730B 291B 3,707B 277B 271B 11,719B | EV / Sales 2026 |
2.51x | EV / Sales 2027 * | 3.66x |
| Free-Float |
73.18% | Yield 2026 * |
1.97% | Yield 2027 * | 1.97% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BDX | Delayed | |
| BDX | Real-time | ||
| BOX | Real-time | ||
| 0R19 | Delayed | ||
| BDX * | End-of-day quote | ||
| BOX | End-of-day quote | ||
| BOX | Delayed | ||
| BOX | Delayed | ||
| BDX | End-of-day quote | ||
| BOX | Real-time | ||
| 1BDX | End-of-day quote | ||
| BDX | Delayed | ||
| BDX | Delayed |
Last Transcript: Becton, Dickinson and Company
| 1 day | -1.23% | ||
| 1 week | +7.29% | ||
| Current month | +7.44% | ||
| 1 month | +15.71% | ||
| 3 months | +18.36% | ||
| 6 months | +42.28% | ||
| Current year | +9.55% |
| 1 week | 206.5 | 216.74 | |
| 1 month | 184.32 | 216.74 | |
| Current year | 140.11 | 216.74 | |
| 1 year | 140.11 | 216.74 | |
| 3 years | 140.11 | 251.98 | |
| 5 years | 140.11 | 287.32 | |
| 10 years | 140.11 | 287.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 53 | 28/01/2020 |
Vitor Roque
DFI | Director of Finance/CFO | 44 | 05/12/2025 |
Ronald Silverman
CTO | Chief Tech/Sci/R&D Officer | 56 | 04/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 75 | 24/09/2002 |
| Director/Board Member | 71 | 26/07/2010 | |
Thomas Polen
CHM | Chairman | 53 | 28/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/10/26 | Sell | Executive/Senior Manager | -76 | 0.0000% | ||
| 28/9/26 | Sell | Executive/Senior Manager | -76 | 0.0000% | ||
| 2/9/26 | Tax | Chief Financial Officer | -190 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.23% | +7.29% | +17.05% | -9.39% | 58.63B | ||
| -0.05% | +0.97% | -12.26% | +17.55% | 191B | ||
| -1.17% | +2.74% | +9.64% | +43.73% | 126B | ||
| -0.44% | +4.42% | -8.66% | +18.52% | 124B | ||
| -1.57% | +0.37% | -39.17% | +6.93% | 98.14B | ||
| +0.85% | +2.41% | -4.37% | +76.50% | 65.98B | ||
| -1.42% | +3.66% | -1.82% | +62.49% | 55.67B | ||
| +0.91% | -2.85% | -5.12% | +54.93% | 48.78B | ||
| +1.08% | +2.42% | +4.85% | -6.69% | 36.03B | ||
| +0.49% | +20.01% | - | - | 35.77B | ||
| Average | -0.26% | +4.24% | -4.43% | +29.40% | 84B | |
| Weighted average by Cap. | -0.43% | +3.32% | -6.86% | +27.66% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 19.29B 17.3B 15.94B 14.48B 27.4B 1,809B 28.17B 191B 76.06B 969B 72.39B 70.86B 3,063B | 19.8B 17.75B 16.36B 14.86B 28.12B 1,856B 28.91B 196B 78.05B 994B 74.29B 72.72B 3,144B |
| Net income | 1.41B 1.26B 1.16B 1.06B 2B 132B 2.05B 13.92B 5.54B 70.64B 5.28B 5.17B 223B | 2.01B 1.8B 1.66B 1.51B 2.86B 188B 2.94B 19.89B 7.93B 101B 7.54B 7.38B 319B |
| Net Debt | 15.88B 14.25B 13.13B 11.92B 22.57B 1,489B 23.2B 157B 62.63B 798B 59.61B 58.35B 2,523B | 14.63B 13.12B 12.09B 10.98B 20.78B 1,371B 21.36B 145B 57.67B 735B 54.9B 53.73B 2,323B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | US$212.61 | -1.23% | 1,790,252 |
| 09/11/26 | US$215.25 | +1.59% | 2,039,094 |
| 06/11/26 | US$211.88 | -0.78% | 2,172,611 |
| 05/11/26 | US$213.55 | +2.08% | 3,991,906 |
| 04/11/26 | US$209.19 | +5.56% | 4,460,588 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BDX Stock
Select your edition
All financial news and data tailored to specific country editions
















